Brendan Scientific (US) launches laboratory software:
This article was originally published in Clinica
Brendan Scientific (US) has launched StatLIA, a laboratory software system. The company says the package connects to all immunoassay instruments and gives QC/QA, data reduction and data management to CLIA requirements - including method and calibration evaluation, instrument performance and lot-to-lot variation. Brendan says the software can cut lab costs by 15% by enabling operators to streamline their procedures.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.